Summary of H.R. 7391: 340B Drug Pricing for Federally-Qualified Health Centers Act

Overview

H.R. 7391, the "340B Drug Pricing for Federally-Qualified Health Centers Act", is a bill introduced in the U.S. House of Representatives on February 5, 2026. The main purpose of the bill is to ensure that Federally-qualified health centers (FQHCs) are not required to pay more than the 340B ceiling price for covered outpatient drugs at the time of purchase.

Key Provisions

The bill would amend Title III of the Public Health Service Act to:

1. Prohibit Overcharging FQHCs: Require drug manufacturers to provide covered outpatient drugs to FQHCs at or below the 340B ceiling price, which is the maximum price drug companies can charge for drugs sold to certain healthcare providers.
2. Enforcement Mechanisms: Establish penalties and enforcement mechanisms to ensure drug manufacturers comply with the 340B price requirements for sales to FQHCs.
3. Reporting Requirements: Mandate drug manufacturers to report to the Secretary of Health and Human Services on their 340B sales and pricing to FQHCs.

Impact and Affected Entities

The key entities and stakeholders that would be impacted by this bill include:

• Federally-Qualified Health Centers (FQHCs): FQHCs provide comprehensive primary and preventive care services in underserved areas. This bill aims to ensure these health centers can access 340B drugs at the intended discounted prices.
• Drug Manufacturers: Drug companies would be required to provide 340B drugs to FQHCs at or below the statutory ceiling price, with penalties for noncompliance.
• Patients Served by FQHCs: By helping FQHCs access 340B drugs at lower costs, this bill could improve affordability and accessibility of prescription drugs for the low-income, uninsured, and underinsured patients treated at these health centers.

Procedural Aspects

• The bill was introduced in the House of Representatives on February 5, 2026 and referred to the House Committee on Energy and Commerce.
• As an introduced bill, it must go through the full legislative process, including potential committee consideration, floor votes in the House and Senate, and either presidential signature or veto to become law.